Mankind Pharma reinvents global supply chain and procurement with Accenture

image credit- freepik

Mankind Pharma has completed a large-scale, multi-year transformation of its global supply chain and strategic procurement function to strengthen access to medicines, improve supply reliability, and support disciplined, scalable growth.

Delivered in collaboration with Accenture, the integrated initiative embeds digitally enabled operating models, powered by advanced analytics and AI, across Mankind Pharma’s procurement, manufacturing, and distribution networks. This is enhancing the company’s ability to manage demand volatility, supply disruptions, and regulatory complexities at scale.

This transformation brings together two critical operating pillars into a unified, end-to-end backbone that tightly links planning intelligence with execution performance. Mankind Pharma has reimagined its global supply chain through an integrated planning platform that connects demand forecasting, manufacturing, inventory, and distribution within a near real-time decision framework across more than 25 international markets.

Powered by advanced analytics and AI-augmented insights, the platform has strengthened forecast accuracy, improved cross-functional alignment, and enabled faster, more responsive planning and execution. In parallel, the company completed an 18-month overhaul of its strategic sourcing and procurement function, reinforcing cost discipline, governance, and supplier collaboration through standardized processes, digital automation, and analytics-led decision-making.

The impact has been tangible and measurable. The customised planning and execution platform deployed across 30 manufacturing facilities and more than 50 distribution centers, has reduced drug stock-outs by 75 per cent and optimized inventory by up to 20 per cent across Mankind Pharma’s global distribution network. The platform has enhanced decision-making, and improved coordination across commercial, manufacturing and supply teams. This has strengthened supply chain performance at scale while maintaining the highest standards of quality and compliance.

Alongside this, the procurement transformation initiative has structurally elevated sourcing as a core business capability for Mankind Pharma. The company clarified sourcing ownership and standardized end-to-end processes to improve efficiency and governance. Digital tools now automate routine activities, enabling teams to focus on strategic decisions and supplier partnerships, while advanced analytics give leadership sharper visibility into spending, supplier performance and supply chain risks.